We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Vaccine development

News List

Outbreak alliance hands Johnson & Johnson, Oxford $18.7M for MERS work and more fiercepharma
November 09, 2018
CEPI, the global outbreak preparedness group, has been busy since it launched last year, raising more than $600 million and handing out grants to back research into
Vaxart touts head-to-head data for oral flu vaccine versus Sanofi's Fluzone fiercepharma
November 09, 2018
Aiming to challenge flu shot market leader Sanofi, Vaxart put up phase 2 data for an oral flu vaccine candidate that the biotech says provided participants both mucosal
J&J touts latest immune response data for 'mosaic' HIV vaccine program fiercepharma
November 09, 2018
Johnson & Johnson has already advanced a “mosaic” HIV vaccine candidate into efficacy testing in five southern African countries, but this week the company unveiled initial
Outbreak alliance hands Johnson & Johnson, Oxford $18.7M for MERS work and more fiercepharma
September 28, 2018
J&J and Oxford University snagged $18.7 million for work on MERS, Lassa and Nipah vaccines.
Chikungunya vaccines: Themis, Bharat Biotech kick off new testing fiercepharma
June 07, 2017
As the hunt to develop the world's first Chikungyuna vaccine persists, two biotechs kicked off tests for their respective programs on Monday.

Previous page 1 2 Next page